Drug intelligence / Profile preview

Fengshengli

Development stage: Preclinical
Lead developer: Fengsheng Nutrition Technology

Overview

Fengshengli is a nutritional supplement developed by Zhejiang Fengsheng Nutrition Technology Co. LTD. It is currently being investigated for its intervention effect on sarcopenia, a condition characterized by age-related muscle loss.

Beyond the preview

Go deeper on Fengshengli.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fengshengli.

Explore the full profile